Prime Medicine Max Drawdown (5Y) Insights

Prime Medicine Inc (PRME)

2.70 +0.06 (+2.27%) USD | NASDAQ | Dec 19, 12:46

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for PRME.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Max Drawdown (5Y) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Max Drawdown Definition

View Max Drawdown Definition

Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks

Start Trial

Bristol-Myers Squibb Co	47.67%
Molecular Templates Inc	99.88%
CEL-SCI Corp	97.97%
AIM ImmunoTech Inc	99.75%
IGC Pharma Inc	97.77%